首页> 外文期刊>Journal of the American Geriatrics Society >Systemic inflammatory response syndrome in nosocomial bloodstream infections with Pseudomonas aeruginosa and Enterococcus Species: comparison of elderly and nonelderly patients.
【24h】

Systemic inflammatory response syndrome in nosocomial bloodstream infections with Pseudomonas aeruginosa and Enterococcus Species: comparison of elderly and nonelderly patients.

机译:铜绿假单胞菌和肠球菌在医院血液感染中的全身炎症反应综合征:老年患者和非老年患者的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To determine whether the systemic inflammatory response syndrome (SIRS), clinical course, and outcome of monomicrobial nosocomial bloodstream infection (BSI) due to Pseudomonas aeruginosa or Enterococcus spp. is different in elderly patients than in younger patients. DESIGN: Historical cohort study. SETTING: An 820-bed tertiary care facility. PARTICIPANTS: One hundred twenty-seven adults with P. aeruginosa or enterococcal BSI. MEASUREMENTS: SIRS scores were determined 2 days before the first positive blood culture through 14 days afterwards. Elderly patients (> or =65, n=37) were compared with nonelderly patients (<65, n=90). Variables significant for predicting mortality in univariate analysis were entered into a logistic regression model. RESULTS: No difference in SIRS was detected between the two groups. No significant difference was noted in the incidence of organ failure, 7-day mortality, or overall mortality between the two groups. Univariate analysis revealed that Acute Physiology And Chronic Health Evaluation (APACHE) II score of 15 or greater at BSI onset; adjusted APACHE II score (points for age excluded) of 15 or greater at BSI onset; and respiratory, cardiovascular, renal, hematological, and hepatic failure were predictors of mortality. Age, sex, use of empirical antimicrobial therapy, and infection with imipenem-resistant P. aeruginosa or vancomycin-resistant enterococci did not predict mortality. Multivariate analysis revealed that hematological failure (odds ratio (OR)=8.1, 95% confidence interval (CI)=2.78-23.47), cardiovascular failure (OR=4.7, 95% CI=1.69-13.10), and adjusted APACHE II > or = 15 at BSI onset (OR=3.1, 95% CI=1.12-8.81) independently predicted death. CONCLUSION: Elderly patients did not differ from nonelderly patients with respect to severity of illness before or at the time of BSI. Elderly patients with pseudomonal or enterococcal BSIs did not have a greater mortality than nonelderly patients.
机译:目的:确定是否由于铜绿假单胞菌或肠球菌引起的全身性炎症反应综合征(SIRS),临床病程和单株医院内血流感染(BSI)的结果。老年患者与年轻患者不同。设计:历史队列研究。地点:拥有820张病床的三级医疗机构。参与者:127名成人的铜绿假单胞菌或肠球菌BSI。测量:SIRS评分是在首次阳性血液培养前2天到之后的14天确定的。将老年患者(>或= 65,n = 37)与非老年患者(<65,n = 90)进行比较。将单变量分析中可预测死亡率的重要变量输入逻辑回归模型。结果:两组之间未发现SIRS差异。两组之间的器官衰竭发生率,7天死亡率或总死亡率没有显着差异。单因素分析显示,BSI发作时的急性生理和慢性健康评估(APACHE)II评分为15分或更高; BSI发作时调整后的APACHE II得分(不包括年龄点)为15或更高;呼吸,心血管,肾脏,血液和肝功能衰竭是死亡率的预测指标。年龄,性别,使用经验性抗菌疗法以及对亚胺培南耐药的铜绿假单胞菌或对万古霉素耐药的肠球菌感染均不能预测死亡率。多变量分析显示,血液学衰竭(几率(OR)= 8.1,95%置信区间(CI)= 2.78-23.47),心血管衰竭(OR = 4.7,95%CI = 1.69-13.10),且调整后的APACHE II>或BSI发作时= 15(OR = 3.1,95%CI = 1.12-8.81)独立预测死亡。结论:在BSI之前或之时,老年患者与非老年患者在疾病严重程度方面没有差异。患有假性或肠球菌性BSI的老年患者的死亡率没有比非老年患者更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号